DAVID H ROSENSTEIN, M.D.
Osteopathic Medicine in Las Vegas, NV
License number
Nevada 11030
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
6970 W. Patrick Ln SUITE 140, Las Vegas, NV 89113
Phone
(702) 450-1717
(702) 947-6740 (Fax)
(702) 947-6740 (Fax)
Organization information
See more information about DAVID H ROSENSTEIN at bizstanding.comDavid H Rosenstein MD
500 N Rainbow Blvd, Las Vegas, NV 89107
Categories:
Emergency & Critical Care Physicians & Surgeons
Phone:
(702) 259-1228 (Phone)
Professional information
David Rosenstein - Las Vegas, NV
Work:
Touro University California Assistant Clinical Professor
Nevada Hospitalist Group Senior Partner
Horizon Specialty Hospital & Desert Lane Care Center
Medical Director of Performance Improvement Desert Springs Hospital Vice Chief University of Nevada Reno - Reno, NV
Las Vegas Clinical Assistant Professor
Medical Director of Performance Improvement Desert Springs Hospital Vice Chief University of Nevada Reno - Reno, NV
Las Vegas Clinical Assistant Professor
Dr. David H Rosenstein, Las Vegas NV - MD (Doctor of Medicine)
Age:
51
Address:
Nevada Hospitalist Group
500 N Rainbow Blvd STE 300, Las Vegas 89107
(702) 450-1717 (Phone)
500 N Rainbow Blvd STE 300, Las Vegas 89107
(702) 450-1717 (Phone)
Hospitals:
Nevada Hospitalist Group
500 N Rainbow Blvd STE 300, Las Vegas 89107
Desert Springs Hospital Medical Center
2075 East Flamingo Rd, Las Vegas 89119
MountainView Hospital
3100 North Tenaya Way, Las Vegas 89128
Summerlin Hospital Medical Center
657 Town Center Dr, Las Vegas 89144
500 N Rainbow Blvd STE 300, Las Vegas 89107
Desert Springs Hospital Medical Center
2075 East Flamingo Rd, Las Vegas 89119
MountainView Hospital
3100 North Tenaya Way, Las Vegas 89128
Summerlin Hospital Medical Center
657 Town Center Dr, Las Vegas 89144
Education:
Medical Schools
University Of Massachusetts Medical School
Graduated: 2001
University Of Massachusetts Medical School
Graduated: 2001
Use Of A Synthetic Alpha-Melanocyte Stimulating Hormone Agonist To Decrease Steroid Induced Weight Gain
US Patent:
2005010, May 12, 2005
Filed:
May 6, 2004
Appl. No.:
10/841961
Inventors:
David Rosenstein - Las Vegas NV, US
Michael Nasiak - Las Vegas NV, US
Michael Nasiak - Las Vegas NV, US
International Classification:
A61K038/22
US Classification:
514012000
Abstract:
People who are on chronic steroids are known to have depressed levels of ACTH and thus should also have decreased levels of α-MSH. Recent data show that people with altered Melanocortin-4 (MC4) receptors (receptor for α-MSH) have strongly associated rates (100%) of Binge Eating Disorder diagnosable of DSM IV criteria. All patients who are on steroids and have low levels of ACTH, and thus low levels of α-MSH, could appear phenotypically identical to those with altered Melanocortin-4 receptors (MC4R). Patients with iatrogenically induced α-MSH deficiencies (including patients on chronic steroid therapy) could be expected to respond to exogenous α-MSH or MC4R agonist supplementation. Exogenous α-MSH or MC4R agonist treatment should also decrease serum leptin levels; therefore, the present invention provides a method of decreasing steroid induced weight gain by employing α-MSH agonists.